reported a dual peptide (RGD and beclin 1) and mPEG–SH functional modified by PDA to obtain PPBR nanoparticles for targeting tumor cells by recognition of αvβ3 receptors and causing cell autophagy by beclin 1 peptide. This evidence concerns the gene BECN1 and neoplasm.